Details of the Drug Reposition

General Information of This Drug (ID: DM5JQ0D)

Drug Name
Streptokinase   DM5JQ0D
Synonyms
Awelysin; Estreptoquinasa; Kabikinase; Streptase; Streptochinasi; Streptokinasum; Streptochinasi [DCIT]; Streptococcal fibrinolysin; Estreptoquinasa [INN-Spanish]; Streptase (TN); Streptokinasum [INN-Latin]; 4-cyclohexylpyrrolidine-2-carboxylic Acid
Therapeutic Class
Thrombolytic Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 4 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute myocardial infarction DISE3HTG BA41 Phase 4 [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Severe acute respiratory syndrome (SARS) DISYW14W 1D65 Discontinued in Phase 3 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00302419) Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03465085) Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS. U.S. National Institutes of Health.